Prevention & lipidsGuideline or statement

Identification and management of cardiopulmonary risk in patients with chronic obstructive pulmonary disease: a multidisciplinary consensus and modified Delphi study

Eur J Prev CardiolPublished

  • Consensus statement (modified Delphi study)
  • multidisciplinary
  • modified Delphi method

Recommendations

As issued by the authors

  1. Given the high burden of fatal and non-fatal major CV and respiratory events in COPD, cardiopulmonary risk should be assessed and managed

  2. Patients with CV risk factors or disease who have regular cough or expectoration, recurrent 'chest infections', a significant smoking history, or dyspnoea should complete spirometry to confirm COPD

  3. Prevalent and incident CVD and risk in COPD (including HF, dyslipidaemia, hypertension, ischaemic heart disease, AF) should be managed according to clinical guidelines

  4. COPD exacerbation risk should be addressed to reduce cardiopulmonary risk

  5. Enhanced integration with specialists in cardiology, pulmonology and primary care is recommended

Original publication

Identification and management of cardiopulmonary risk in patients with chronic obstructive pulmonary disease: a multidisciplinary consensus and modified Delphi study. Eur J Prev Cardiol. Published 3 March 2025. doi:10.1093/eurjpc/zwaf119

Summarised from the published abstract; every number is checked against it